Neuropsychiatric symptoms in patients with probable Progressive supranuclear palsy in reference centers of Valle del Cauca- Colombia
Objective: To evaluate the neuropsychiatric symptoms in patients with probable Progressive supranuclear palsy attended in reference centers of the Valle del Cauca, Colombia, between 2020 and…The Clinical Landscape of Progressive Supranuclear Palsy in an Underserved Community from Southwestern Colombia
Objective: To elucidate the clinical presentation of Progressive Supranuclear Palsy (PSP) in a cohort residing in underserved communities in Buenaventura, Colombia—the country's primary maritime port…Exploring Vestibulopathy in PD: Distinguishing PD from Age-related Presbyvestibulopathy via Dynamic Gait and Balance Assessment
Objective: To investigate the influence of age-associated vestibulopathy (presbyvestibulopathy, PVP) on dynamic gait and balance in Parkinson's disease (PD) patients and elderly controls. We hypothesized…CSF Neurogranin Levels Are Decreased in Parkinson Disease
Objective: To investigate CSF neurogranin differences in participants with Parkinson disease (PD) and controls and to examine its association with motor and cognitive symptoms. Background:…Prediction of Time-to-Phenoconversion to Parkinsonism in Idiopathic REM Sleep Behavior Disorder (iRBD)
Objective: To develop a tool for the prediction of time-to-phenoconversion in individuals with iRBD during the prodromal stage of parkinsonism. Background: Parkinson’s disease(PD) and dementia…A Case of Concurrent Wilson Disease and Parkinson Disease
Objective: to present a case of concurrent Wilson disease and Parkinson disease. Background: Wilson disease (WD) is a rare autosomal recessive disease that typically manifests…Salivary and Plasma Heme Oxygenase-1 Concentration as a New Potential Biomarker in Parkinson Disease
Objective: The objective was to assess the utility of plasma and salivary heme oxygenase-1 (HO-1) concentration as a new potential biomarker for the diagnosis of…AI for Personalized Medication Management in Parkinson’s Disease
Objective: To assess medication usage over time in Parkinson’s Disease utilizing AI in EHR data. Background: Parkinson's disease (PD) is a complex neurodegenerative disorder characterized…Cardiovascular Associations of Cortical Lewy Bodies in the Oldest Old: The 90+ study
Objective: To identify potential risk factors for cortical Lewy Bodies (CLB) in the oldest-old (> 90 years old), we investigated if cardiovascular medical histories, medication…Preventing Treatment Disruptions: The Crucial Role of Outpatient Nurses and Multidisciplinary Collaboration in Managing Skin Complications during Foslevodopa/Foscarbidopa Therapy
Objective: The objective of this research was to explore the pivotal role of outpatient nurses in mitigating skin complications and facilitating uninterrupted treatment for Parkinson's…
- « Previous Page
- 1
- …
- 13
- 14
- 15
- 16
- 17
- …
- 1554
- Next Page »